{"id":"W3134153606","doi":"10.1200/jco.2021.39.6_suppl.101","title":"Network meta-analysis (NMA) comparing the efficacy of enzalutamide versus apalutamide, darolutamide, and bicalutamide for treatment of nonmetastatic (nm) castration-resistant prostate cancer (CRPC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Enzalutamide; Bicalutamide; Medicine; Prostate cancer; Internal medicine; Oncology; Placebo; Androgen deprivation therapy; Androgen receptor; Clinical endpoint; Antiandrogen; Prostate-specific antigen; Clinical trial; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03266869,0.003813541,0.01424263,0.006876271,0.000564204,0.002874957,0.002630243,0.002768455,0.00625441],"category_scores_gemma":[0.05415195,0.001332006,0.06635322,0.005004718,0.0006634988,0.002223114,0.002602309,0.00364363,0.0005901182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002207048,"about_ca_system_score_gemma":0.002419919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008814,"about_ca_topic_score_gemma":0.01059509,"domain_scores_codex":[0.9604636,0.03074959,0.003034128,0.003576286,0.001647618,0.0005287887],"domain_scores_gemma":[0.9660121,0.02922887,0.00222052,0.00133992,0.0008169733,0.0003817409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.005735317,0.0000251747,0.004080134,0.02379933,0.9594327,0.00007145758,0.00002970976,0.002253042,0.0001542936,0.0001996679,0.0007424718,0.003476636],"study_design_scores_gemma":[0.002185992,0.0003654118,0.00301237,0.001349863,0.9890152,0.00006356463,0.00002046095,0.001878518,0.00008860241,0.0005791206,0.001416068,0.00002474179],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.08651866,0.8487414,0.02762095,0.003113591,0.00318061,0.004161439,0.02067886,0.0009281358,0.005056289],"genre_scores_gemma":[0.8764459,0.07618913,0.02327751,0.002485772,0.0008226135,0.009530216,0.008771687,0.0002668133,0.00221035],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03266869,"threshold_uncertainty_score":0.1727706,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4256698579627413,"score_gpt":0.5246021642651568,"score_spread":0.09893230630241556,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}